Individuals’ CSF Aβ42 and P181-tau concentrations for (A) both Control groups, subjects with amnestic Mild Cognitive Impairment (MCI), and patients with Alzheimer’s Disease (AD), and for (B) patients with Parkinson’s disease (PD) without cognitive impairment (CI), with CI but Not Dementia (PD-CIND), or dementia (PD-D).